Bms
Bristol Myers Squibb (BMS), a leading biopharmaceutical company headquartered in the United States, has been at the forefront of medical innovation since its founding in 1887. With a strong presence in North America, Europe, and Asia, BMS focuses on discovering, developing, and delivering innovative medicines for serious diseases, particularly in oncology, immunology, and cardiovascular health. BMS is renowned for its core products, including the groundbreaking cancer therapies Opdivo and Yervoy, which have transformed treatment paradigms. The company’s commitment to research and development has positioned it as a market leader, achieving significant milestones such as the successful launch of multiple life-saving therapies. With a robust pipeline and a dedication to patient-centric solutions, Bristol Myers Squibb continues to make a profound impact on global health.
DitchCarbon Score
How does Bms's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bms's score of 34 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bms's reported carbon emissions
In 2023, BMS reported total carbon emissions of approximately 2,117,929,000 kg CO2e. This figure includes 208,535,000 kg CO2e from Scope 1 emissions, 158,447,000 kg CO2e from Scope 2 emissions, and 1,750,947,000 kg CO2e from Scope 3 emissions. Notably, the Scope 3 emissions encompass significant contributions from purchased goods and services, which accounted for about 1,353,368,000 kg CO2e. Over the years, BMS has demonstrated a commitment to reducing its carbon footprint. In 2022, the total emissions were approximately 2,142,307,000 kg CO2e, indicating a slight decrease in emissions in 2023. The company has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, suggesting a need for further transparency in their climate commitments. BMS's emissions data reflects a trend of decreasing total emissions from a peak of approximately 2,244,138,000 kg CO2e in 2021. The company continues to report emissions across all three scopes, highlighting the importance of addressing both direct and indirect emissions in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 21,054,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 000,000,000 | 00,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 15,079,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 000,000,000 | 00,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 6,963,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bms is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
